PHS
ALXN
PFM Health Sciences’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-901,441
| Closed | -$166M | – | 91 |
|
|
2021
Q2 | $166M | Sell |
901,441
-158,190
| -15% | -$29.1M | 5.19% | 1 |
|
|
2021
Q1 | $162M | Buy |
1,059,631
+78,500
| +8% | +$12M | 4.95% | 2 |
|
|
2020
Q4 | $153M | Buy |
981,131
+277,314
| +39% | +$43.3M | 5.39% | 1 |
|
|
2020
Q3 | $80.5M | Buy |
703,817
+24,933
| +4% | +$2.85M | 3.72% | 4 |
|
|
2020
Q2 | $76.2M | Sell |
678,884
-7,365
| -1% | -$827K | 3.95% | 2 |
|
|
2020
Q1 | $61.6M | Sell |
686,249
-390,193
| -36% | -$35M | 5.06% | 1 |
|
|
2019
Q4 | $116M | Sell |
1,076,442
-370,170
| -26% | -$40M | 5.55% | 1 |
|
|
2019
Q3 | $142M | Buy |
+1,446,612
| New | +$142M | 4.18% | 3 |
|
|
2017
Q1 | – | Sell |
-133,605
| Closed | -$16.3M | – | 121 |
|
|
2016
Q4 | $16.3M | Buy |
+133,605
| New | +$16.3M | 0.46% | 57 |
|
|
2015
Q1 | – | Sell |
-70,987
| Closed | -$13.1M | – | 101 |
|
|
2014
Q4 | $13.1M | Buy |
+70,987
| New | +$13.1M | 0.31% | 71 |
|